Predictors of nasolacrimal duct intubation failure for primary acquired nasolacrimal duct obstruction——A CT dacryocystography study

Author:

Wang Wushuang1,Lin Tong1,Gong Lan1,Wang Yan1

Affiliation:

1. Eye & ENT Hospital of Fudan University

Abstract

Abstract Background: Whether to choose nasolacrimal duct intubation or dacryocystorhinostomy (DCR) for primary acquired nasolacrimal duct obstruction (PANDO) therapy is an important question in clinic practice. The purpose of this study is to find the potential lacrimal sac characteristics which can be used for the predictors of unsuccessful intubation for PANDO based on computed tomography-dacryocystography (CT-DCG). Methods: In this retrospective comparative observational study, we included PANDO patients who had a history of failed intubation for nasolacrimal duct obstruction as intubation failure group, and PANDO patients without intubation history as control group. We analyzed the lacrimal sac height, lacrimal sac width and obstruction site based on CT-DCG, all measured based on several reference levels on axial sections (upper, intermediate, lower level, common canaliculus level and lowermost contrast level), which were defined according to the contrast and the bony structure. Results: A total of 114 sides of PANDO were studied, including 36 sides in intubation failure group the other 78 sides in control group. The intubation failure group showed smaller lacrimal sac height (11.69±4.59 mm) and width (2.28±1.97 mm, intermediate level) than control group (14.13±2.92 mm, 3.32±2.02 mm, P = 0.005 and 0.012, respectively). Intubation failure group showed higher obstruction site than control group (P = 0.009). Conclusions: A small lacrimal sac and a high obstruction site are predictors of nasolacrimal duct intubation failure for PANDO. For PANDO patients with small lacrimal sac or high obstruction position, DCR is more recommended than intubation.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3